You are here: Industry Insights > Alzheimer’s disease

News List

Biogen signs two deals to address neurological disorders pharmaceutical-technology
January 08, 2019
Biogen has signed a strategic collaboration with US-based drug maker C4 Therapeutics for the discovery and development of new therapies to treat neurological diseases, including Alzheimer’s disease.
PET tracer able to image tau in Alzheimer’s disease patients europeanpharmaceuticalreview
December 07, 2018
Research into detecting tau proteins in the brains of Alzheimer’s patients has shown that a specific tracer could detect and measure the protein levels…
Benzodiazepines associated with increased risk of Alzheimer’s disease: Study financialexpress
August 16, 2018
The medication is commonly used for sleep problems, but its effectiveness for this indication diminishes over weeks or months
Viruses may play a role in Alzheimer’s disease biospectrumasia
June 25, 2018
The research group and Arizona State University, Phoenix, originally set out to find whether drugs used to treat other diseases can be repurposed for treating Alzheimer’s.
Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab b3cnewswire
May 08, 2018
Biogen (Nasdaq: BIIB) and Neurimmune announced today that Biogen has exercised its option to further reduce the previously negotiated royalty rates payable on potential future sales of aducanumab...
Long-term PPI use does not increase hip fracture risk in Alzheimer’s patients europeanpharmaceuticalreview
March 22, 2018
Researchers have found that the long-term proton pump inhibitor use does not increase the risk of hip fracture among persons with Alzheimer’s disease…
Review of Drugs for Alzheimer’s Disease—Lucky Stars, Fallen Stars and Future Stars of Patients Erxiao
February 13, 2018
The pharmaceutical giants that entered early in the field have suffered R&D setbacks and quit, but this does not stop other companies from continuing to seek the light of victory.
Blood test detects early stages of Alzheimer’s disease europeanpharmaceuticalreview
February 06, 2018
Scientists have developed and validated a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials…
New study shows anti-ulcer drugs do not increase risk of Alzheimer’s disease pharmaceutical-technology
August 10, 2017
A new study by the University of Eastern Finland has revealed that use of a type of anti-ulcer drug, proton pump inhibitors, does not increase the risk of Alzheimer’s disease.
Alzheon to present new clinical data and analyses for ALZ-801 cphi-online
February 16, 2017
The presentations highlight Alzheon’s ‘precision medicine’ approach to drug development for Alzheimer’s disease.

Previous page 1 2 3 Next page